Mateusz Kaczmarek, Author at TechStock²

Social Security COLA 2026 and the $200 Boost Bill: How Much Your Check Could Really Rise (Update for November 17, 2025)

Let’s break down what’s locked in, what’s still just a proposal, and what it all means for your 2026 Social Security income as of today, November 17, 2025. 1. The 2026 COLA is official: 2.8% across Social Security and SSI

17 November 2025

Personal Finance·Retirement Planning·Social Security

Rivian Stock (RIVN) Today: Price Targets Raised, Battery Bug Emerges and Big Holders Trim Stakes – November 17, 2025

Rivian Automotive, Inc. (NASDAQ: RIVN) is having another eventful Monday. After a huge post‑earnings rally, the electric‑vehicle maker is now caught between bullish Wall Street upgrades, negative headlines about a battery‑calibration problem, and fresh disclosures showing big investors trimming their

17 November 2025

Company Updates·Electric Vehicles·Financial Analysis·Investment News·Stock Market

Tesla (TSLA) News Today: China Supply Chain Shake-Up, Thiel Trims Stake, AI5 Delay and Divided Wall Street – 17 November 2025

Tesla (TSLA) stock edges higher on November 17, 2025 as Elon Musk accelerates a shift away from China-made parts, Peter Thiel slashes his stake, AI5 chip timelines slip, and analysts clash over robotaxi upside vs. “tough reality.” TSLA stock today:

17 November 2025

Electric Vehicles·Stock Market·Tesla News·Wall Street

Ford Stock Soars in 2025 as Wall Street Backs EV Reset, Hybrids and an Amazon-Powered Digital Pivot

Ford Motor Company (NYSE: F) has quietly become one of 2025’s unlikeliest comeback stories. After years of a sluggish share price, the stock is up roughly one‑third this year, outpacing the broader market, even as its electric‑vehicle unit bleeds billions

17 November 2025

Digital Transformation·Electric Vehicles·Investment Trends·Stock Market

Metsera (MTSR) Delists as Pfizer Closes Up to $10 Billion Obesity Drug Deal – All the Key Updates on November 17, 2025

Pfizer’s acquisition of Metsera, Inc. (formerly NASDAQ: MTSR) is now effectively complete, Metsera’s stock has been delisted, major index providers are removing the name, and antitrust scholars are using the failed Novo Nordisk bid as a case study in “attempted

17 November 2025

Biotechnology·Healthcare Industry·Mergers & Acquisitions·Pharma News

Opendoor (OPEN) News Today: Warrant Dividend, Short Seller Crackdown and Wall Street Caution — November 17, 2025

Opendoor Technologies (NASDAQ: OPEN) is back in the spotlight as a controversial warrant dividend aimed at short sellers dominates headlines, even as Morgan Stanley reiterates a Hold rating and quants flag huge hedge fund flows. Here’s everything investors need to

17 November 2025

Financial Reports·Investment Strategies·Stock Market News

Ondas Holdings (ONDS) Lands $8.2M Airport Drone Defense Deal and Closes $225M Sentrycs Acquisition on November 17, 2025

Ondas Holdings Inc. (NASDAQ: ONDS), a provider of autonomous drone systems and private wireless networks, packed several major announcements into Monday, November 17, 2025 – including a new multimillion‑dollar European airport contract, the closing of a $225 million acquisition, and

17 November 2025

Business News·Drone Technology·Mergers and Acquisitions

Light & Wonder (ASX:LNW): ASX‑Only Listing, $1.5bn Buyback Shift and Fresh Fund Moves – 17 November 2025 Update

Light & Wonder, Inc. (ASX: LNW, formerly NASDAQ: LNW) has hit a turning point this week. As of 17 November 2025, the cross‑platform gaming group has fully completed its move to a sole listing on the Australian Securities Exchange (ASX),

17 November 2025

ASX News·Investment Updates·Market Analysis

Beyond Meat (BYND) Stock News Today, November 17, 2025: Class Action Probe, Meme-Stock Hangover and Heavy Dilution Risks

Beyond Meat, Inc. (NASDAQ: BYND) is back in the spotlight today as fresh legal scrutiny, shifting short interest, and lingering questions about its debt restructuring collide with a battered share price hovering just above the $1 mark. As of today,

17 November 2025

Company Analysis·Financial News·Investing·Legal Issues·Stock Market

Tonix Pharmaceuticals (TNXP) Jumps as TONMYA, First New Fibromyalgia Drug in 15 Years, Hits U.S. Pharmacies – November 17, 2025

Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) moved sharply higher today after the company confirmed that TONMYA™ (cyclobenzaprine HCl sublingual tablets), its newly approved fibromyalgia treatment, is now commercially available by prescription across the United States. GlobeNewswire TONMYA Officially Launches in

17 November 2025

Healthcare News·Pharmaceuticals

Galmed Pharmaceuticals (GLMD) Soars on New Cancer Drug Combo Data: What Today’s Breakthrough Means for Investors – November 17, 2025

As of this afternoon, Galmed Pharmaceuticals shares were changing hands around $1.18, up roughly 13% on the day, with more than 41 million shares traded—massively above the stock’s usual daily volume. TipRanks What Galmed Announced Today From its headquarters in

17 November 2025

Biotechnology·Cancer Research·Investment News·Pharmaceuticals·Stock Market

Autonomix Medical (AMIX) Stock Doubles on New Pancreatic Cancer Quality‑of‑Life Data – November 17, 2025 Update

All of today’s Autonomix (AMIX) news in one glance – 17 November 2025 As of this afternoon on November 17, 2025, all company‑specific news about Autonomix Medical, Inc. (NASDAQ: AMIX) centers on the same core development: new quality‑of‑life data from

17 November 2025

Biotechnology·Cancer Research·Investment Analysis·Stock Market